125 related articles for article (PubMed ID: 7994412)
1. Characteristics of neo red cells, their function and safety: in vivo studies.
Ogata Y; Goto H; Sakaguchi K; Suzuki M; Ohsaki K; Suzuki K; Saniabadi AR; Kamitani T; Takahashi A
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):875-81. PubMed ID: 7994412
[TBL] [Abstract][Full Text] [Related]
2. Characterization of neo red cells (NRCs), their function and safety in vivo tests.
Takahashi A
Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):347-54. PubMed ID: 7493056
[TBL] [Abstract][Full Text] [Related]
3. Development of neo red cells (NRC) with the enzymatic reduction system of methemoglobin.
Ogata Y; Goto H; Kimura T; Fukui H
Artif Cells Blood Substit Immobil Biotechnol; 1997 Jul; 25(4):417-27. PubMed ID: 9242936
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the oxygen transport capacity of NRCs with a 70% blood exchange in rats.
Tsutsui Y; Asakawa Y; Goto H; Kimura T; Ogata Y
Artif Cells Blood Substit Immobil Biotechnol; 1998 Nov; 26(5-6):465-75. PubMed ID: 9844713
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of polylipid/Hb vesicles (ARC) (in vitro and in vivo test).
Nakachi O; Tokuyama S; Satoh T; Tsuchida E
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):635-40. PubMed ID: 1391487
[TBL] [Abstract][Full Text] [Related]
6. Oxygen transport and in vivo parameters of artificial red cells (ARC).
Akama K; Morizawa K; Tokuyama S; Satoh T; Kobayashi K; Sekiguchi S; Tsuchida E
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):901-7. PubMed ID: 7994416
[TBL] [Abstract][Full Text] [Related]
7. Circulation persistence and biodistribution of lyophilized liposome-encapsulated hemoglobin: an oxygen-carrying resuscitative fluid.
Rudolph AS; Cliff RO; Klipper R; Goins B; Phillips WT
Crit Care Med; 1994 Jan; 22(1):142-50. PubMed ID: 8124957
[TBL] [Abstract][Full Text] [Related]
8. Physiological responses, organ distribution, and circulation kinetics in anesthetized rats after hypovolemic exchange transfusion with technetium-99m-labeled liposome-encapsulated hemoglobin.
Goins B; Klipper R; Sanders J; Cliff RO; Rudolph AS; Phillips WT
Shock; 1995 Aug; 4(2):121-30. PubMed ID: 7496897
[TBL] [Abstract][Full Text] [Related]
9. Effects of exchange transfusion with liposome-encapsulated hemoglobin on VO₂/DO₂.
Ikegawa H; Kuwagata Y; Hayakawa K; Noguchi K; Ogura H; Sugimoto H
Artif Organs; 2012 Feb; 36(2):130-8. PubMed ID: 22171966
[TBL] [Abstract][Full Text] [Related]
10. Effect of liposome-encapsulated hemoglobin, neo red cells, on hemorrhagic shock.
Usuba A; Osuka F; Kimura T; Sato R; Ogata Y; Gotoh H; Kimura T; Fukui H
Surg Today; 1998; 28(10):1027-35. PubMed ID: 9786574
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute.
Phillips WT; Klipper RW; Awasthi VD; Rudolph AS; Cliff R; Kwasiborski V; Goins BA
J Pharmacol Exp Ther; 1999 Feb; 288(2):665-70. PubMed ID: 9918573
[TBL] [Abstract][Full Text] [Related]
12. Preparation of virus-free pyridoxylated hemoglobin from the blood of HBV or HTLV-I healthy carriers.
Sekiguchi S; Ito K; Kobayashi M; Ototake N; Kosuda M; Kwon KW; Ikeda H
Biomater Artif Cells Artif Organs; 1988; 16(1-3):113-21. PubMed ID: 3179462
[TBL] [Abstract][Full Text] [Related]
13. The ability of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) to adequately deliver oxygen in both exchange transfusion and top-loaded rat models.
Conover CD; Linberg R; Shum KL; Shorr RG
Artif Cells Blood Substit Immobil Biotechnol; 1999 Mar; 27(2):93-107. PubMed ID: 10092932
[TBL] [Abstract][Full Text] [Related]
14. Liposome encapsulated hemoglobin: long-term storage stability and in vivo characterization.
Cliff RO; Ligler F; Goins B; Hoffmann PM; Spielberg H; Rudolph AS
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):619-26. PubMed ID: 1391485
[TBL] [Abstract][Full Text] [Related]
15. Hemoglobinuria in rats: a sensitive test of renal filtering and absorption of PEG-hemoglobin, a red blood cell substitute.
Gilbert C; Nho K; Johnson M; Linberg R; Shorr R
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):535-41. PubMed ID: 7994375
[TBL] [Abstract][Full Text] [Related]
16. Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute.
Sou K; Klipper R; Goins B; Tsuchida E; Phillips WT
J Pharmacol Exp Ther; 2005 Feb; 312(2):702-9. PubMed ID: 15459236
[TBL] [Abstract][Full Text] [Related]
17. Encapsulated hemoglobin: current issues and future goals.
Rudolph AS
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(2):347-60. PubMed ID: 8087251
[TBL] [Abstract][Full Text] [Related]
18. PEG-hemoglobin: an efficient oxygen-delivery system in the rat exchange transfusion and hypovolemic shock models.
Nho K; Linberg R; Johnson M; Gilbert C; Shorr R
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):795-803. PubMed ID: 7994402
[TBL] [Abstract][Full Text] [Related]
19. Performances of PEG-modified hemoglobin-vesicles as artificial oxygen carriers in microcirculation.
Sakai H; Tsuchida E
Clin Hemorheol Microcirc; 2006; 34(1-2):335-40. PubMed ID: 16543654
[TBL] [Abstract][Full Text] [Related]
20. Liposome-encapsulated hemoglobin using film hydration processing to form artificial red blood cells.
Deshpande SV; Beissinger RL
Biomater Artif Cells Immobilization Biotechnol; 1993; 21(2):135-51. PubMed ID: 8318608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
